Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Go back to Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update| (NASDAQ: CRNX) | Delayed: 84.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $84.95 | 52 Week High | $ | |||
| Open | $84.95 | 52 Week Low | $ | |||
| Day High | $84.95 | P/E | N/A | |||
| Day Low | $84.95 | EPS | $ | |||
| Volume | 1,494,532 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 528.90 -17.22 (3.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $546.12 | 52 Week High | $134.71 | |||
| Open | $529.64 | 52 Week Low | $73.31 | |||
| Day High | $535.00 | P/E | N/A | |||
| Day Low | $520.20 | EPS | $-1.98 | |||
| Volume | 1,121,341 | |||||
